Short-term prognosis of polypharmacy in elderly patients treated in emergency departments: results from the EDEN project.
Jesús RuízAitor Alquézar-ArbéAna Juanes BorregoGuillermo Burillo PutzeSira AguilóJavier JacobCesáreo FernándezPere LlorensFrancisco de Borja Quero EspinosaSusana Gordo RemartinezRocio Hernando GonzálezMiguel Moreno MartínSara Sánchez ArocaAlicia Sara KnabeRebeca González GonzálezMarina Carrión FernándezAlberto Artieda LarrañagaMaria Adroher MuñozJeong-Uh Hong ChoMaría Teresa Escolar Martínez BerganzaSara Gayoso MartínGoretti Sánchez SindínMartina Silva PenasBárbara Gómez Y GómezRoser Arenos SambroJuan González Del CastilloÒscar MiróPublished in: Therapeutic advances in drug safety (2024)
Polypharmacy was common among the elderly treated in EDs and associated with increased risks of ED revisits and hospital readmissions ⩽30 days but not with an increased risk of 30-day mortality. Patients with polypharmacy had a higher risk of ED revisits and hospital readmissions ⩽30 days after discharge.